In the hush after midnight, when the city lights soften and quiet stretches across empty streets, our bodies sometimes whisper warnings we cannot ignore. A new pulse of medical concern is rising across America — not loud, but persistent — among those who once turned to cannabis for comfort or relief.
Recent research reveals that a syndrome linked to long-term cannabis use is increasingly showing up in emergency rooms: recurring, severe bouts of nausea, abdominal pain, and vomiting so intense people reportedly scream as they vomit — a harrowing phenomenon colloquially dubbed “scromiting.”
The condition, known as Cannabinoid Hyperemesis Syndrome (CHS), tends to appear after years of chronic cannabis use, often in individuals who start young and consume frequently. Doctors describe its hyper-emetic phase as brutal: episodes can last 24–48 hours, with repeated vomiting sometimes reaching up to five times per hour, paired with severe abdominal cramps.
In a comprehensive study covering emergency-department visits across the United States from 2016 through 2022, researchers found suspected CHS cases increased significantly, especially after 2020 — in part attributed to heightened stress, isolation, and increased cannabis use during the pandemic. Though numbers dipped somewhat in 2022, they remained noticeably above pre-pandemic baselines.
What stands out is not just the rise, but the confusion and delay in diagnosis. Because CHS mimics other gastrointestinal disorders — food poisoning, stomach flu, general vomiting syndromes — patients often endure repeated episodes before physicians connect the dots.
Treatment offers little relief for many. Common anti-nausea medications often fail; instead, patients may resort to frequent hot baths or showers, which — for unknown reasons — temporarily alleviate symptoms. Ultimately, the only reliable “cure” appears to be cessation of cannabis use, though for long-time users, that can be difficult.
This trend raises broader questions. As cannabis becomes more widely legalized and its potency rises, are we fully aware of the long-term health costs? Are occasional or medical users also at risk, or only heavy chronic users? Why does the syndrome appear in some and not others? The science remains unclear — but the human toll is evident.
Perhaps what this surge in “scromiting” cases asks of us is not only caution and awareness, but humility. A once-common assumption — that cannabis is benign, or even healing — is being challenged by silent alarms in emergency rooms. For societies embracing or debating legalization, this should prompt not moral panic, but measured reflection, informed policy, and honest public health messaging.
As clinicians and researchers continue to investigate CHS, one thing is certain: the rush of euphoria that cannabis may offer does not make the body immune to consequences. And when the quiet returns after a storm of sickness, survivors may carry more than memory — a reminder that even refuge can harbor risk.
In the end, the rise of CHS and scromiting is not a reason for alarmist headlines — but for clear eyes. A reminder that every remedy, like every relief, comes with its shadows.
AI image disclaimer Graphics are generated via AI tools and meant for representation only, not real photographs.
Sources University of Washington School of Medicine / ScienceDaily, Cleveland Clinic, IFLScience, Fox News, World-Today News, Gizmodo
Published by Banx Network. This article is part of the Banx decentralized media programme, powered by the BXE token on the XRP Ledger.
